So many women have been told their exhaustion, weight gain, and mood swings are 'just menopause' — only to later discover an underactive thyroid had been quietly driving half the symptoms the whole time. The frustrating truth is that both diagnoses are real, both deserve treatment, and neither one automatically rules out the other. Getting a full thyroid panel alongside hormone testing isn't overcautious — it's just sensible medicine.
Learn more about Rose →Both hypothyroidism and perimenopause cause a bone-deep tiredness that sleep doesn't reliably fix. In thyroid disease, low T3 and T4 slow cellular metabolism throughout the body, reducing energy production at a fundamental level. In perimenopause, disrupted sleep architecture from night sweats and declining oestrogen creates a fatigue that feels similar but tends to be worse on days following poor sleep rather than constant and weather-independent. A key distinguishing clue: thyroid fatigue often persists even after a genuinely good night's sleep, whereas perimenopausal fatigue is more clearly tethered to sleep quality.
Cognitive sluggishness — losing words, forgetting what a sentence was about mid-way through, struggling to concentrate — is reported by women with both hypothyroidism and perimenopause, making it one of the most diagnostically unhelpful symptoms in isolation. Oestrogen supports hippocampal function and neurotransmitter activity, so its decline in perimenopause genuinely impairs verbal memory and processing speed. Thyroid hormones are equally essential to neurological function; even subclinical hypothyroidism has been associated with measurable cognitive slowing in multiple studies. When brain fog is prominent and persistent regardless of sleep, thyroid function testing is particularly warranted.
Unexplained weight gain — particularly around the abdomen — is frequently attributed to menopause, but hypothyroidism is an equally common culprit and the two can operate simultaneously. Thyroid hormones regulate basal metabolic rate, and even modest TSH elevation slows calorie burning enough to cause gradual but persistent weight accumulation. Perimenopausal weight gain is driven more by shifts in fat distribution caused by declining oestrogen and rising cortisol than by a metabolic slowdown of the same magnitude. If weight gain is substantial and accompanied by constipation, cold intolerance, or puffy skin, thyroid disease deserves serious investigation rather than reflexive attribution to midlife hormonal change.
Both conditions are well-documented causes of anxiety, irritability, low mood, and in some cases clinical depression, making mood symptoms among the most difficult to attribute correctly. Hypothyroidism classically causes low mood and emotional flatness, while hyperthyroidism more often drives anxiety, restlessness, and panic-like episodes. Perimenopause can produce the full spectrum — anxiety, depression, and rapid mood cycling — particularly in women with a prior history of PMS or postnatal depression, who appear to be more neurobiologically sensitive to hormonal fluctuation. The pattern of mood changes over the menstrual cycle, if periods are still occurring, can offer useful clues: perimenopausal mood symptoms often track with cycle phase, while thyroid-driven mood changes tend to be more constant.
Menstrual irregularity is a hallmark of perimenopause as ovarian reserve declines and cycle-regulating hormones fluctuate, but both hypothyroidism and hyperthyroidism independently disrupt the menstrual cycle through entirely different mechanisms. Hypothyroidism can cause heavy, frequent periods or irregular cycles by interfering with the hypothalamic-pituitary axis and elevating prolactin levels. Hyperthyroidism more often causes light, infrequent, or absent periods. Because thyroid dysfunction and perimenopause can produce near-identical cycle disruption, thyroid testing is a standard recommendation whenever menstrual irregularity first presents — and is unfortunately not always carried out.
Hot flushes are one of the most iconic menopause symptoms, triggered by oestrogen withdrawal's effect on the hypothalamic thermostat, producing sudden intense heat from the chest upward. Hyperthyroidism produces a different but easily confused version: a persistent generalised warmth, heat intolerance, and sweating that lacks the distinct wave-like onset of a flush. Cold intolerance, on the other hand — feeling perpetually chilly when others are comfortable — points far more strongly toward hypothyroidism than menopause. If a woman reports cold hands, cold feet, and needing extra layers year-round alongside other midlife symptoms, thyroid function should be checked before assuming menopause explains everything.
Poor sleep is nearly universal in perimenopause, primarily driven by night sweats interrupting sleep cycles and by oestrogen and progesterone's direct effects on sleep architecture and GABA activity. Thyroid dysfunction also disrupts sleep in distinct ways: hyperthyroidism causes difficulty falling asleep and reduced slow-wave sleep due to sympathetic nervous system overactivation, while hypothyroidism is associated with excessive sleeping yet unrefreshing sleep and, in some cases, sleep apnoea. Women who snore heavily or wake with headaches alongside their sleep complaints may have thyroid-related sleep apnoea rather than — or in addition to — hormonally disrupted sleep.
Thinning hair is distressing at any age, and in midlife it becomes particularly hard to attribute because both declining oestrogen and thyroid disease are legitimate independent causes. Perimenopausal hair changes typically present as diffuse thinning across the scalp as oestrogen — which prolongs the hair growth phase — declines and androgens become relatively more dominant. Hypothyroidism causes hair loss that can extend to the outer third of the eyebrows (a reasonably specific clinical sign), affect body hair, and produce a dry, coarse hair texture that differs from the finer thinning more typical of hormonal hair loss. Examining where the hair loss is concentrated and whether eyebrow thinning is present is a simple first step toward distinguishing the two.
Heart palpitations — the uncomfortable awareness of one's own heartbeat — are common in perimenopause, most often triggered by hot flushes, anxiety, or oestrogen's direct influence on cardiac electrical activity. Hyperthyroidism is a serious and frequently overlooked cause of palpitations, tachycardia, and in older women, atrial fibrillation, because excess thyroid hormone directly stimulates cardiac beta receptors. The distinction matters clinically: perimenopausal palpitations are usually benign, while hyperthyroid-driven palpitations carry cardiovascular risk and require prompt treatment. Any woman reporting palpitations alongside weight loss, heat intolerance, tremor, or increased bowel frequency should have thyroid function checked urgently rather than waiting for a menopause diagnosis to be confirmed.
Declining oestrogen in perimenopause reduces skin collagen, hydration, and elasticity, causing dryness, thinning, and loss of firmness — changes that are gradual and tend to affect the skin's texture evenly. Hypothyroidism produces a more pronounced and specific appearance: a doughy puffiness particularly around the eyes and face caused by the accumulation of glycosaminoglycans in the skin (myxoedema), dry skin with a yellowish tint due to impaired beta-carotene conversion, and cracked heels. If facial puffiness is notable or skin changes feel more dramatic than expected for the degree of hormonal change, thyroid disease is worth ruling out explicitly, as these changes reverse with adequate treatment.
A normal TSH result is often presented as definitive evidence that the thyroid is not contributing to symptoms, but TSH alone can miss subclinical dysfunction, conversion problems (where T4 is not being adequately converted to the active T3), and autoimmune thyroid disease (Hashimoto's) in its early phases. A more complete picture includes free T3, free T4, and thyroid antibodies (TPO and TgAb) — tests that are not always ordered as standard and may need to be requested directly. Women in perimenopause are also worth knowing that oestrogen therapy can raise thyroid-binding globulin, which affects thyroid hormone availability and may alter the dose of levothyroxine needed in women already on treatment, meaning thyroid management and menopause treatment interact in ways that require monitoring.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.